Hi Daz - I am not calling $0.52c good. I am calling $0.35c good. Those rough prices are my conservative calculations and are based on the revenue forecasts contained in the Maxim report of July last year. They state that their model only includes cardiocel in CHD and heart valve repair. No allowance for vaccines or vascucel or the curved patch. Maxim had a $2.00 target price. I certainly hope that the share price will be well north of $0.52c by 2018.
Hi Daz - I am not calling $0.52c good. I am calling $0.35c good....
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.10 |
Change
-0.050(0.33%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $47.50K | 3.124K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 328 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 2024 | 2 |
View Market Depth
| Last trade - 12.15pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |